Mergers & Acquisitions


Current filters:


Popular Filters

767 to 791 of 896 results

Valeant ups its bid for ISTA Pharma


California, USA-based ophthalmology and allergy drug company ISTA Pharmaceuticals (Nasdaq: ISTA) says…

ISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalRespiratory and PulmonaryValeant Pharmaceuticals

Merck & Co out to lead in hepatitis C


US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company’s…

Anti-viralsMerck & CoMergers & AcquisitionsPharmaceuticalResearch

2011 a bumper year for Pharma, Biotech and Generics M&A


Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011


Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

Shire gets US Rights to Resolor


Ireland-headquartered specialty biopharma firm Shire (LSE: SHP) says that it has acquired the rights…

Gastro-intestinalsMarkets & MarketingMergers & AcquisitionsNorth AmericaPharmaceuticalResolorShire

Ownership change for BioLigands ApS


The founding shareholders in BioLigands ApS together with UK based biotech Bridge BioResearch have taken…

BioLigandsMergers & AcquisitionsPharmaceutical

Bristol-Myers to buy hep C drug developer for $2.5 billion


Looking to bolster its drug pipeline in the face of US patent expiry of one of its best selling drugs,…

Anti-viralsBristol-Myers SquibbInhibitexMergers & AcquisitionsPharmaceutical

Smith & Nephew to spin-out biologics and clinical therapies unit


Texas, USA-based venture capital firm Essex Woodlands has entered into a strategic partnership with the…

BiotechnologyBioventusMergers & AcquisitionsSmith & Nephew

Cornerstone acquires Cardiokine


US specialty drugmaker Cornerstone Therapeutics (Nasdaq: CRTX) said yesterday that it has acquired Cardiokine,…

Cardio-vascularCardiokineCornerstone TherapeuticslixivaptanMergers & AcquisitionsMetabolicsPharmaceutical

Accelrys acquires VelQuest for $35 million


Scientific enterprise R&D software and services company Accelrys (Nasdaq: ACCL) says that it has acquired…

AccelrysMergers & AcquisitionsPharmaceuticalResearchVelQuest

STADA pulls out of part of Grunenthal deal


German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

Biotech predictions for 2012 from sector specialist Steven Burrill


As 2011 drew to a close, Steven Burrill, chief executive of global life sciences financial services firm…

BiotechnologyFinancialMergers & AcquisitionsNorth AmericaPharmaceuticalRegulation

Alexion to buy Enobia Pharma for potential $1 billion


US drugmaker Alexion Pharmaceuticals (Nasdaq: ALXN) has reached agreement to acquire privately held Canadian…

Alexion Pharmaceuticalsasfotase alfaEnobia PharmaMergers & AcquisitionsPharmaceuticalRare diseases

Apricus Biosciences closes Topotarget USA acquisition


Apricus Biosciences (Nasdaq: APRI) has closed its previously-announced acquisition of Topotarget USA,…

Apricus BioscienceMergers & AcquisitionsOncologyPharmaceuticalTopotargetTotect

ViroPharma buys option to acquire Meritage Pharma


ViroPharma (Nasdaq: VPHM) has entered into an exclusive option to acquire fellow USA based Meritage Pharma,…

BudesonideMergers & AcquisitionsMeritage PharmaPharmaceuticalRare diseasesResearchViroPharma

Lundbeck divests three branded injectables to Akorn


Danish CNS drug specialist Lundbeck (LUND: DC) says it has entered into an agreement with USA-based niche…

AkornCogentinDiurilGenericsLundbeckMergers & AcquisitionsNembutalNeurologicalNorth AmericaPharmaceutical

OPKO Health buys API developer


Miami, USA-based OPKO Health (NYSE: OPK), which is controlled by Israeli generics giant Teva Pharmaceutical…

FineTech PharmaceuticalGenericsMergers & AcquisitionsOPKO HealthTeva Pharmaceutical Industries

Covis acquires US rights for GlaxoSmithKline brands


Covis Pharma, a Switzerland-based specialty pharmaceutical company owned by affiliates of Cerberus Capital…

Covis PharmaGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

GlaxoSmithKline divests batch of OTC brands for $660 million, but still more to go


The widely expected sale of UK pharma giant GlaxoSmithKline (LSE: GSK) non-prescription brands was confirmed…

GlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Zydus Cadila acquires Mumbai-based Biochem


Indian drug firm Zydus Cadila says it has acquired a 100% stake in Biochem, described as one of the top…

Antibiotics and Infectious diseasesAsia-PacificBiochemGenericsMergers & AcquisitionsZydus Cadila

Takeda boosts oncology pipeline with acquisition


Japan’s largest drugmaker Takeda Pharmaceutical (TYO: 4502), via a US subsidiary, has entered into…

IntellikineMergers & AcquisitionsOncologyPharmaceuticalTakeda Pharmaceuticals

Acino buys more Cephalon/Mepha businesses


Swiss branded and generic drugmaker Acino Pharma (SIX: ACIN) and Israel’s Teva Pharmaceutical Industries…

Acino PharmaCephalonGenericsMephaMergers & AcquisitionsTeva Pharmaceutical Industries

767 to 791 of 896 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top